Copyright
©The Author(s) 2019.
World J Hepatol. Jun 27, 2019; 11(6): 522-530
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.522
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.522
Grade of HE | PPI user | PPI nonuser |
n = 75 | n = 28 | |
Grade 1 | 15 (20.0) | 11 (39.3) |
Grade 2 | 32 (46.6) | 13 (46.4) |
Grade 3 | 18 (24.0) | 4 (14.3) |
Grade 4 | 10 (13.4) | 0 (0) |
Variables | Total, n = 103 | PPI user, n = 75 | PPI nonuser, n = 28 | P value |
Age, yr, Mean ± SD | 58.3 (10.8) | 59.6 (10.6) | 55.3 (10.7) | 0.044a |
Sex, male, n (%) | 71 (58.7) | 54 (63.5) | 17 (47.2) | 0.143 |
On lactulose, n (%) | 92 (76) | 63 (74.1) | 29 (80) | 0.599 |
Bleeding in last 12 mo, n (%) | 39 (32.2) | 26 (30.6) | 13 (36.1) | 0.703 |
Infection, n (%) | ||||
Clostridium difficile colitis | 5 (4.1) | 5 (5.9) | 0 (0) | 0.324 |
Pneumonia | 11 (9.1) | 10 (11.8) | 1 (2.8) | 0.220 |
Spontaneous bacterial peritonitis | 9 (7.4) | 5 (5.9) | 4 (11.1) | 0.533 |
Serum ammonia level, Mean ± SD | 61.1 (67.2) | 67.8 (67.8) | 45.5 (64.2) | 0.095 |
Grade of hepatic encephalopathy, Mean ± SD | 2.1 (0.9) | 2.3 (0.9) | 1.7 (0.7) | 0.001b |
MELD score, Mean ± SD | 19.9 (7.2) | 19.7 (7.4) | 20.3 (6.7) | 0.687 |
Length of stay in d, Mean ± SD | 8.5 (7.0) | 8.3 (7.9) | 6.5 (3.7) | 0.046a |
Required ICU, n (%) | 33 (27.3) | 27 (31.8) | 6 (16.7) | 0.138 |
Expired, n (%) | 11 (9.1) | 10 (11.8) | 1 (2.8) | 0.220 |
Variables | Β ± SE | P value |
Model 1, demographic variables | ||
Age | -0.001 ± 0.001 | 0.871 |
Sex | 0.062 ± 0.167 | 0.710 |
PPI use | 0.607 ± 0.180 | 0.001b |
Model 2, medical comorbidities | ||
Age | 0.002 ± 0.008 | 0.787 |
Sex | 0.043 ± 0.166 | 0.797 |
MELD Score | 0.020 ± 0.011 | 0.079 |
PPI Use | 0.607 ± 0.179 | < 0.001b |
Model 3, other medications | ||
Age | 0.004 ± 0.008 | 0.647 |
Sex | 0.033 ± 0.164 | 0.839 |
MELD Score | 0.024 ± 0.011 | 0.041a |
Lactulose | 0.324 ± 0.189 | 0.089 |
PPI use | 0.625 ± 0.178 | < 0.001b |
- Citation: Fasullo M, Rau P, Liu DQ, Holzwanger E, Mathew JP, Guilarte-Walker Y, Szabo G. Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients. World J Hepatol 2019; 11(6): 522-530
- URL: https://www.wjgnet.com/1948-5182/full/v11/i6/522.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i6.522